GLP1R and metabolic dysfunction-associated steatotic liver disease: Studies have indicated that dysbiosis of the gut microbiota and its metabolites can stimulate GLP-1 secretion via the GPR41/43 pathway, leading to fat accumulation and the development of NAFLD [36].